Showing results (1201-1210 of 6,326) with videos related to
Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|November 12, 2024
De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D)Paloma Rodriguez, Nikki Breslaw, Huijun Xiao, et al.Diabetes, Obesity & Metabolism|October 29, 2024
Visit-to-visit HbA1c variability and risk of potentially avoidable hospitalisations in adults with type 2 diabetes receiving outpatient care at a tertiary hospitalHtet Lin Htun, Weixiang Lian, Hwee Pin Phua, et al.Diabetes, Obesity & Metabolism|November 8, 2024
The association between android-to-gynoid lean mass ratio and all-cause and specific-cause mortality in US adults: A prospective studyYuxin Fan, Li Ding, Wei Li, et al.Diabetes, Obesity & Metabolism|October 29, 2024
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY studyVictor Wasehuus, Viktor Rotbain Curovic, Nete Tofte, et al.Diabetes, Obesity & Metabolism|August 9, 2024
Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programmeJean-François Yale, Atheline Major-Pedersen, Andrei-Mircea Catarig, et al.Diabetes, Obesity & Metabolism|August 8, 2024
The dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in micePedro H Reis-Barbosa, Ilitch Marcondes-de-Castro, Thatiany S Marinho, et al.Diabetes, Obesity & Metabolism|August 9, 2024
Cystic fibrosis-related diabetes develops from a combination of insulin secretion defects and insulin resistanceMarie-Ève Bolduc, Kathryn J Potter, Maxime Olmos, et al.Diabetes, Obesity & Metabolism|August 9, 2024
Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China studyLinong Ji, Yiming Mu, Cuiqing Chang, et al.Diabetes, Obesity & Metabolism|July 9, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 studyKyung Ah Han, You-Cheol Hwang, Shin Je Moon, et al.Diabetes, Obesity & Metabolism|July 10, 2024
Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trialRichard Kazibwe, Matthew Singleton, Michael P Bancks, et al.Pageof 633